Oxytocin and Stress Response in Alcohol Use Disorder
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
Individuals with alcohol use disorder (AUD) will complete one functional Magnetic Resonance
Imaging (fMRI) scanning visit. Prior to the scan, individuals will receive a nasal spray of
either 24 international units (IU) of oxytocin (OT), or placebo (PBO). During the scan, they
will perform the Montreal Imaging Stress Task (MIST), a social stress task. Subjective
craving and anxiety data will be collected.